A citation-based method for searching scientific literature

Jaclyn F Hechtman, Ryma Benayed, David M Hyman, Alexander Drilon, Ahmet Zehir, Denise Frosina, Maria E Arcila, Snjezana Dogan, David S Klimstra, Marc Ladanyi, Achim A Jungbluth. Am J Surg Pathol 2017
Times Cited: 190



Sarah Chiang, Paolo Cotzia, David M Hyman, Alexander Drilon, William D Tap, Lei Zhang, Jaclyn F Hechtman, Denise Frosina, Achim A Jungbluth, Rajmohan Murali, Kay J Park, Robert A Soslow, Esther Oliva, A John Iafrate, Ryma Benayed, Marc Ladanyi, Cristina R Antonescu. Am J Surg Pathol 2018
Times Cited: 92




List of shared articles



Times cited

Developing Drugs for Tissue-Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine.
Nathan D Seligson, Todd C Knepper, Susanne Ragg, Christine M Walko. Clin Pharmacol Ther 2021
7

Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
Iva Brčić, Theresa Maria Godschachner, Marko Bergovec, Jasminka Igrec, Holger Till, Herwig Lackner, Susanne Scheipl, Karl Kashofer, Thomas Brodowicz, Andreas Leithner,[...]. Mod Pathol 2021
9

Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Amir Momeni-Boroujeni, Nissreen Mohammad, Robert Wolber, Stephen Yip, Martin Köbel, Brendan C Dickson, Martee L Hensley, Mario M Leitao, Cristina R Antonescu, Ryma Benayed,[...]. Mod Pathol 2021
2

NTRK and other recently described kinase fusion positive uterine sarcomas: A review of a group of rare neoplasms.
Sabrina Croce, Isabelle Hostein, W Glenn McCluggage. Genes Chromosomes Cancer 2021
2

Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer.
Esther Conde, Susana Hernandez, Elena Sanchez, Rita Maria Regojo, Carmen Camacho, Marta Alonso, Rebeca Martinez, Fernando Lopez-Rios. Arch Pathol Lab Med 2021
2

Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
Hidetaka Yamamoto, Yui Nozaki, Azusa Sugii, Kenichi Taguchi, Takahiro Hongo, Rina Jiromaru, Masanobu Sato, Takafumi Nakano, Kazuki Hashimoto, Minako Fujiwara,[...]. Hum Pathol 2021
0

Neurofibrosarcoma Revisited: An Institutional Case Series of Uterine Sarcomas Harboring Kinase-related Fusions With Report of a Novel FGFR1-TACC1 Fusion.
Kelly A Devereaux, Julianna J Weiel, Anne M Mills, Christian A Kunder, Teri A Longacre. Am J Surg Pathol 2021
2

NTRK fusions and Trk proteins: what are they and how to test for them.
Lawrence M Weiss, Vincent A Funari. Hum Pathol 2021
0

[How to test for NTRK gene fusions: A practical approach for pathologists].
Arnaud Uguen, Marie Csanyi-Bastien, Jean-Christophe Sabourin, Frédérique Penault-Llorca, Julien Adam. Ann Pathol 2021
0

Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma.
Simon Strohmeier, Iva Brcic, Helmut Popper, Bernadette Liegl-Atzwanger, Jörg Lindenmann, Luka Brcic. Sci Rep 2021
1

MLH1/PMS2 Expression Could Tell Classical NTRK Fusion in Fluorescence In Situ Hybridization Positive Colorectal Carcinomas.
Yao Fu, Zheng Li, Fuping Gao, Jun Yang, Hongyan Wu, Biao Zhang, Xiaohong Pu, Xiangshan Fan. Front Oncol 2021
0

Update on Cutaneous Soft Tissue Tumors.
Josephine K Dermawan, Jennifer S Ko, Steven D Billings. Surg Pathol Clin 2021
0

The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies.
Antonio Russo, Lorena Incorvaia, Umberto Malapelle, Marzia Del Re, Ettore Capoluongo, Bruno Vincenzi, Rita Chiari, Laura Cortesi, Romano Danesi, Ada Maria Florena,[...]. Crit Rev Oncol Hematol 2021
0

Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
Luiza N Weis, Sara M Tolaney, Carlos H Barrios, Romualdo Barroso-Sousa. NPJ Breast Cancer 2021
0

Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer.
Derek Wong, Stephen Yip, Poul H Sorensen. Pathol Oncol Res 2020
16

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
James P Solomon, Irina Linkov, Andrea Rosado, Kerry Mullaney, Ezra Y Rosen, Denise Frosina, Achim A Jungbluth, Ahmet Zehir, Ryma Benayed, Alexander Drilon,[...]. Mod Pathol 2020
135

Colonic Adenocarcinomas Harboring NTRK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature.
Jerzy Lasota, Małgorzata Chłopek, Jennifer Lamoureux, Jason Christiansen, Artur Kowalik, Bartosz Wasąg, Anna Felisiak-Gołąbek, Abbas Agaimy, Wojciech Biernat, Vincenzo Canzonieri,[...]. Am J Surg Pathol 2020
27

What's new in fibroblastic tumors?
Susan M Armstrong, Elizabeth G Demicco. Virchows Arch 2020
2

Uterine mesenchymal tumours: recent advances.
Amir Momeni-Boroujeni, Sarah Chiang. Histopathology 2020
14


NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
Joseph T Rabban, W Patrick Devine, Ankur R Sangoi, Liina Poder, Edwin Alvarez, Jessica L Davis, Erin Rudzinski, Karuna Garg, Gregory R Bean. Histopathology 2020
19

Myxoid Spindle Cell Sarcoma With LMNA-NTRK Fusion: Expanding the Morphologic Spectrum of NTRK-Rearranged Tumors.
Yik Ka So, Chit Chow, Ka Fai To, John K C Chan, W Cheuk. Int J Surg Pathol 2020
8

TRK inhibition in soft tissue sarcomas: A comprehensive review.
Tarek Assi, Elie Rassy, Hussein Nassereddine, Fadi Farhat, Fadi El Karak, Joseph Kattan, Marwan Ghosn. Semin Oncol 2020
5

NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm.
Daniel D Wong, Ana Cristina Vargas, Fiona Bonar, Fiona Maclean, Joseph Kattampallil, Colin Stewart, Ban Sulaiman, Leonardo Santos, Anthony J Gill. Pathology 2020
10